The test-retest reproducibility of [11C]PK11195 positron emission tomography using Biograph Vision Quadra scanner [0.03%]
生物光视Quadra扫描仪的[11C]PK11195正电子发射断层扫描的测试-重测再现性
Tanja Sjöros,Markus Matilainen,Virva Saunavaara et al.
Tanja Sjöros et al.
Background: Positron emission tomography (PET) imaging of the 18 kDa translocator protein (TSPO) is a method to quantify central inflammation and particularly microglial activation, which is increased in progressive multi...
Reconstruction matters: influence of EARL standards and BSREM in [18F]FET PET for distinguishing glioma progression from treatment-related changes [0.03%]
重建成像的重要性：EARL标准和BSREM对[18F]FET-PET区分胶质瘤进展与治疗相关变化的影响
J de Jong,M Segbers,A A Harteveld et al.
J de Jong et al.
Background: Differentiating progressive disease (PD) from treatment-related changes (TRC) in glioma remains challenging using magnetic resonance imaging (MRI) alone. Amino acid positron-emission tomography (PET) with O-(2...
[18F]FDG PET/CT is a quantitative tool to probe vascular inflammation and immune system metabolic activation in atherosclerotic nonhuman primates [0.03%]
[18F]FDG正电子发射型计算机断层显像/ X线计算机体层成像技术能够定量化探究非人灵长类动脉粥样硬化血管炎症以及免疫系统代谢活化情况
Hee-Jeong Yang,Hui Wang,Russell Byrum et al.
Hee-Jeong Yang et al.
Background: Atherosclerosis is a major global health concern, necessitating advanced research models to better understand pathophysiology and inform potential interventions. Due to their physiological similarities to huma...
Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods [0.03%]
朝向可重复的子宫内膜癌代谢肿瘤体积定量：优化[¹⁸F]fdg pet/ct肿瘤分割方法
Kristine Eldevik Fasmer,Sunniva Lindås,Ankush Gulati et al.
Kristine Eldevik Fasmer et al.
Background: Metabolic tumor volume (MTV) derived from [18F]FDG PET/CT has shown promise in improving preoperative staging and prognostication in endometrial cancer, both as a standalone biomarker and as a foundation for P...
Fully automatic left ventricle segmentation in [Formula: see text]Rb PET/CT Using a semi-supervised nnU-net [0.03%]
使用半监督nnU-Net在[Rb PET/CT上进行全自动左心室分割
Mohammadreza Amirian,Arthur Chevalley,María Martín Asiain et al.
Mohammadreza Amirian et al.
Background: Quantification of myocardial blood flow (MBF) with [Formula: see text]Rb PET/CT requires accurate delineation of the left ventricle (LV). Manual or semi-automated contouring remains time-consuming and error-pr...
Dialysis-related amyloidosis mimicking metastatic bone disease: a scintigraphic pitfall of non-MDP-avid osteolytic lesions on bone SPECT/CT [0.03%]
模拟转移性骨病的透析相关性淀粉样变：非MDP亲和溶骨病变骨SPECT/CT影像上的一个“陷阱”
Tzyy-Ling Chuang,Chih-En Tseng,Po-Hsun Lin et al.
Tzyy-Ling Chuang et al.
Background: Dialysis-related amyloidosis (DRA) is a recognized complication of long-term dialysis caused by progressive deposition of β2-microglobulin amyloid in osteoarticular and periarticular tissues. Although its mus...
Noninvasive tracking of myocardial fibrosis in pressure-overload heart failure with [68Ga]Ga-FAPI-04 PET/CT [0.03%]
使用[68Ga]Ga-FAPI-04正电子发射断层扫描/X线计算机体层成像非侵入性追踪压力超负荷心力衰竭中心肌纤维化
Shanshan Liu,Hui Wen,Bingqing Han et al.
Shanshan Liu et al.
Background: Myocardial fibrosis is a major driver of heart failure progression, yet noninvasive tools to track its activity are limited. We evaluated fibroblast activation protein (FAP)-targeted [68Ga]Ga-FAPI-04 (FAPI = F...
Glypican-3 targeted radiopharmaceuticals for hepatocellular carcinoma: a review of molecular platforms [0.03%]
肝细胞癌中glypican-3靶向放射性药物：分子平台综述
Yue Sun,Lin Qiu
Yue Sun
Background: Hepatocellular carcinoma (HCC) is characterized by high heterogeneity, making early diagnosis and systemic therapy challenging. Glypican-3 (GPC-3) targeted radiopharmaceuticals are promising tools for HCC. Thi...
Simultaneous partial volume correction and denoising of brain PET images, using transformers and transfer learning [0.03%]
基于变压器和迁移学习的脑PET图像的同时部分容积校正和去噪方法
Sanaz Kaviani,Amirhossein Sanaat,Mersede Mokri et al.
Sanaz Kaviani et al.
Background: Positron emission tomography (PET) is a key tool for quantitative brain imaging, but its image quality and quantitative reliability are strongly dependent on injected radiotracer activity and acquisition time....
From imaging heterogeneity to clinical decision: a novel imaging biomarker based on bone marrow kinetics for advanced NSCLC patients in partial response [0.03%]
从影像异质性到临床决策：基于骨髓动力学的新型影像生物标志物用于局部晚期NSCLC患者的治疗反应评估
Yubo Wang,Zhiheng Yao,Jingjing Wan et al.
Yubo Wang et al.
Background: Risk of disease progression varies substantially among advanced non-small cell lung cancer (NSCLC) patients who achieve a partial response to initial therapy, and this subgroup currently lacks practical progno...